Together, the evidence of NOPr involvement in dopamine and glutamate signaling, given the localization patterns and modulatory roles, suggests considerable potential for NOPr signaling in the pathophysiology of schizophrenia. The gene discussed is OPRL1; the disease is schizophrenia.